pharma news today obesity drugs glp-1 today health october 2025 Outlook for obesity in 2025: more GLP-1 Antagonists Increase Plan Drug

In studies with rats or mice, Trulicity and medicines that work like Trulicity caused thyroid tumors, including thyroid cancer

[22] compared glucose metabolism parameters and post-prandial GLP-1 levels before and after MBS between patients with active or inactive Crohns Disease and healthy controls

From Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity: In the remote study, we observe a significantly lower self-reported intake of alcohol, drinks per drinking episode, binge drinking odds, Alcohol Use Disorders Identification Test (AUDIT) scores, and stimulating, and sedative effects in the Semaglutide or Tirzepatide group when compared to prior to starting medication timepoint (within-subjects) and the control group (between-subjects)

Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity Diabetes Care

Here are the key results from landmark trials that established its clinical credibility